InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Davis Aaron I., Director. Insider active across 6 companies, notably Odonate Therapeutics, Inc.. Cumulatively, 11 disclosures have been published. Split: 2 buys · 3 sells. Total volume traded: €11.2m. History available since 17 November 2021. The latest transaction was disclosed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Davis Aaron I.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
79,726 sharesCommon Stock, par value $0.001 per shareSEC:0001999371-24-000965:0
43,073 sharesCommon StockSEC:0001140361-24-003538:0
6,808 shares@ US$58.75100.0% of flowCommon StockSEC:0001628280-24-000357:0
5,000 shares0Common StockSEC:0000899243-23-015012:0
4,444 shares0Common StockSEC:0001214659-23-001050:0
972,212 shares@ US$5.83100.0% of flowCommon StockSEC:0000899243-22-035366:0
Canonical exit: 2 Feb 2023 (T+90)
25,000 shares@ US$22.908910.7% of flowCommon StockSEC:0000899243-22-017712:0
150,000 shares@ US$27.402177.2% of flowCommon StockSEC:0000899243-22-016203:0
21,300 shares@ US$31.87512.2% of flowCommon StockSEC:0000899243-22-012152:0
Canonical exit: 20 Jun 2022 (T+90)
2,546 shares0Common StockSEC:0001214659-22-000842:0
170,000 shares@ US$2.2334100.0% of flowCommon StockSEC:0000899243-21-045438:0
11 of 11 declarations
About Davis Aaron I.
Davis Aaron I. is a Director of Mirati Therapeutics, Inc., iTeos Therapeutics, Inc., Rain Oncology Inc., Tango Therapeutics, Inc., Rain Therapeutics Inc. and Odonate Therapeutics, Inc. He has 11 filings in total, and across the 11 sampled filings between 2021-11-19 and 2024-01-26, the buy and sell amounts are 6429801 and 4790443 euros respectively, with Attribution as the most frequent transaction nature.
